R&D channel feed – Endpoints News

R&D channel feed

Parker Institute for Cancer Immunotherapy invests another $125M into research

10 months ago

J&J ditches epilepsy development with Addex, blindsiding 20-year partner

10 months ago

Roche touts Phase 3 Susvimo data in diabetes-related ophthalmic diseases

10 months ago

KRAS cancer drug eased symptoms of rare and serious blood vessel condition in two patients, new study shows

10 months ago

FDA thwarts Agenus' accelerated approval plans for CTLA-4/PD-1 combo in 'disappointing' move

10 months ago

Gilead chief medical officer Merdad Parsey to leave company early next year

10 months ago

Roche declares early win for oral GLP-1 drug it bought from Carmot

10 months ago

4DMT builds out case for wet AMD gene therapy with new Phase 2 data

10 months ago

Genentech parts ways with Relay Therapeutics on SHP2 after other pharma exits

10 months ago

Adverum prepares pivotal study for wet AMD gene therapy, touts Phase 2 data

10 months ago

Caribou to slash preclinical allogeneic CAR-NK work, lay off 12% of staff

10 months ago

Renalys raises $37.8M to take Travere's kidney disease drug into Phase 3 trial in Japan

10 months ago

After a handful of stumbles, argenx doubles down on pipeline-in-a-product strategy as it pitches investors

10 months ago

A teenager faced constant seizures. Could a drug developed just for him stop them?

10 months ago

Roche details early obesity data from GLP-1/GIP agonist, plans for Phase 2 study this year

10 months ago

Revolution Medicines' RAS inhibitor shows promise in early-stage pancreatic cancer trial

10 months ago

Updated: Lexeo Therapeutics' gene therapy shows potential for Friedreich's ataxia cardiomyopathy with early data

10 months ago

Lilly says lupus drug dropped from pipeline failed to show efficacy

10 months ago

Indivior axes schizophrenia drug and shrinks revenue guidance

10 months ago

Immutep’s LAG-3 drug scores in Phase 2b head and neck cancer test

10 months ago

Pfizer presses forward with once-daily GLP-1 pill in long-awaited move

10 months ago

Ipsen takes on another ADC, this time from a China-based biotech

10 months ago

AbbVie CSO Tom Hudson to retire, replaced by medical chief

10 months ago

In less-studied female mice, scientists find hormone that could lead to new bone disease treatments

10 months ago

First page Previous page 36 37 383940 41 42 Next page Last page